MX2015011804A - Metodos y composiciones para diagnosticar preeclampsia. - Google Patents
Metodos y composiciones para diagnosticar preeclampsia.Info
- Publication number
- MX2015011804A MX2015011804A MX2015011804A MX2015011804A MX2015011804A MX 2015011804 A MX2015011804 A MX 2015011804A MX 2015011804 A MX2015011804 A MX 2015011804A MX 2015011804 A MX2015011804 A MX 2015011804A MX 2015011804 A MX2015011804 A MX 2015011804A
- Authority
- MX
- Mexico
- Prior art keywords
- preeclampsia
- compositions
- methods
- population
- patients
- Prior art date
Links
- 201000011461 pre-eclampsia Diseases 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000012544 monitoring process Methods 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se proveen en la presente métodos, composiciones y kits para el uso de agentes de unión para detectar la presencia de proteínas de la PEE y/o autoanticuerpos de la PEE en una muestra biológica de una mujer embarazada; dichos métodos y composiciones son útiles para predecir el inicio de la preeclampsia, monitorear la progresión de la preeclampsia, monitorear la regresión de la preeclampsia, evaluar la eficacia de tratamiento de la preeclampsia, identificar una sub-población de pacientes quienes deben ser tratados por la preeclampsia, y/o identificar una subpoblación de pacientes quienes deben ser monitoreados por los síntomas de la preeclampsia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361785934P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/029741 WO2014153232A2 (en) | 2013-03-14 | 2014-03-14 | Methods and compositions for diagnosing preeclampsia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015011804A true MX2015011804A (es) | 2016-07-19 |
| MX366272B MX366272B (es) | 2019-07-04 |
Family
ID=51581776
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015011804A MX366272B (es) | 2013-03-14 | 2014-03-14 | Metodos y composiciones para diagnosticar preeclampsia. |
| MX2019008005A MX2019008005A (es) | 2013-03-14 | 2015-09-07 | Metodos y composiciones para diagnosticar preeclampsia. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019008005A MX2019008005A (es) | 2013-03-14 | 2015-09-07 | Metodos y composiciones para diagnosticar preeclampsia. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160003838A1 (es) |
| EP (2) | EP2972344B1 (es) |
| JP (2) | JP6400670B2 (es) |
| KR (1) | KR20150140657A (es) |
| CN (1) | CN105308455B (es) |
| AU (1) | AU2014236152B2 (es) |
| BR (1) | BR112015021507A8 (es) |
| CA (1) | CA2901551A1 (es) |
| HK (1) | HK1217761A1 (es) |
| MX (2) | MX366272B (es) |
| WO (1) | WO2014153232A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2657772C1 (ru) * | 2017-07-06 | 2018-06-15 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский институт акушерства и гинекологии" Министерства здравоохранения Московской области | Способ профилактики гестационных осложнений у беременных с эпилепсией |
| JP2020532732A (ja) | 2017-09-01 | 2020-11-12 | ヴェン バイオサイエンシズ コーポレーション | 診断および治療モニタリングのためのバイオマーカーとしての糖ペプチドの同定および使用 |
| CN114895041A (zh) * | 2021-07-01 | 2022-08-12 | 浙江大学 | 一种检测抗蛋白酶体亚基α1-IgG抗体的试剂盒 |
| CA3241918A1 (en) * | 2022-01-31 | 2023-08-03 | Hector Han-Li HUANG | Biomarkers for diagnosing preeclampsia |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
| EP1716419A2 (en) * | 2004-02-20 | 2006-11-02 | AplaGen GmbH | Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility. |
| CA2561684A1 (en) * | 2004-04-09 | 2005-11-17 | Joseph M. Ahearn | Real time method of detecting acute inflammatory conditions |
| US20080254482A1 (en) * | 2006-11-22 | 2008-10-16 | Invitrogen Corporation | Autoimmune disease biomarkers |
| AU2008207746B2 (en) * | 2007-01-26 | 2013-09-05 | University Of Louisville Research Foundation, Inc. | Methods of detecting autoantibodies for diagnosing and characterizing disorders |
| KR100932942B1 (ko) * | 2007-07-10 | 2009-12-21 | 인제대학교 산학협력단 | 자간전증의 진단을 위한 바이오마커 및 조성물 |
| CN107677828A (zh) * | 2008-10-31 | 2018-02-09 | 耶鲁大学 | 子痫前期检测和治疗的方法和组合物 |
| US20100144055A1 (en) * | 2008-11-07 | 2010-06-10 | Nanosphere, Inc. | Assays For Clinical Assessments of Disease-Associated Autoantibodies |
-
2014
- 2014-03-14 CN CN201480013907.XA patent/CN105308455B/zh not_active Expired - Fee Related
- 2014-03-14 US US14/774,776 patent/US20160003838A1/en not_active Abandoned
- 2014-03-14 AU AU2014236152A patent/AU2014236152B2/en not_active Ceased
- 2014-03-14 MX MX2015011804A patent/MX366272B/es active IP Right Grant
- 2014-03-14 JP JP2016503212A patent/JP6400670B2/ja not_active Expired - Fee Related
- 2014-03-14 CA CA2901551A patent/CA2901551A1/en not_active Abandoned
- 2014-03-14 BR BR112015021507A patent/BR112015021507A8/pt not_active Application Discontinuation
- 2014-03-14 WO PCT/US2014/029741 patent/WO2014153232A2/en active Application Filing
- 2014-03-14 KR KR1020157026036A patent/KR20150140657A/ko not_active Application Discontinuation
- 2014-03-14 EP EP14768554.9A patent/EP2972344B1/en active Active
- 2014-03-14 EP EP19150937.1A patent/EP3543694A1/en not_active Withdrawn
-
2015
- 2015-09-07 MX MX2019008005A patent/MX2019008005A/es unknown
-
2016
- 2016-05-18 HK HK16105681.5A patent/HK1217761A1/zh not_active IP Right Cessation
-
2018
- 2018-09-05 JP JP2018165612A patent/JP2018205327A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018205327A (ja) | 2018-12-27 |
| WO2014153232A2 (en) | 2014-09-25 |
| EP2972344A2 (en) | 2016-01-20 |
| KR20150140657A (ko) | 2015-12-16 |
| EP2972344A4 (en) | 2017-02-08 |
| AU2014236152B2 (en) | 2019-08-01 |
| CA2901551A1 (en) | 2014-09-25 |
| AU2014236152A1 (en) | 2015-09-17 |
| CN105308455B (zh) | 2019-04-09 |
| CN105308455A (zh) | 2016-02-03 |
| EP3543694A1 (en) | 2019-09-25 |
| HK1217761A1 (zh) | 2017-01-20 |
| JP6400670B2 (ja) | 2018-10-03 |
| MX366272B (es) | 2019-07-04 |
| MX2019008005A (es) | 2019-08-29 |
| BR112015021507A8 (pt) | 2019-11-19 |
| US20160003838A1 (en) | 2016-01-07 |
| EP2972344B1 (en) | 2019-01-16 |
| JP2016517528A (ja) | 2016-06-16 |
| WO2014153232A3 (en) | 2014-12-24 |
| BR112015021507A2 (pt) | 2017-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
| ZA201604468B (en) | Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis | |
| EP3839510A3 (en) | Blood-based biomarkers of tumor sensitivity to pd-1 antagonists | |
| MX2016002423A (es) | Composiciones y metodos de diagnostico para el tratamiento de glioblastoma. | |
| MX2020008976A (es) | Biomarcadores y su uso en el tratamiento de condiciones relacionadas con pd-1 y pd-l1. | |
| EA201590630A1 (ru) | Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2) | |
| WO2013008102A3 (en) | Methods and compositions for evaluating and/or treating chronic immune diseases | |
| GB2463401B (en) | Characterizing prostate disorders by analysis of microvesicles | |
| MX2020010947A (es) | Metodos de tratamiento de enfermedad de alzheimer. | |
| WO2012006589A3 (en) | Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling | |
| MX342735B (es) | Diagnostico acompañante para terapia con agente anti-hialuronano y metodos de uso del mismo. | |
| WO2014036495A3 (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
| MX2014003422A (es) | Método para la monitorización, el diagnostico y/o el pronostico de lesión renal aguda en fase temprana. | |
| NZ729773A (en) | Biomarkers for disease progression in melanoma | |
| AR080361A1 (es) | Identificacion, evaluacion y terapia de canceres con resistencia innata o adquirida a inhibidores de quinasa del linfoma anaplasico (alk) | |
| WO2011047033A3 (en) | Biomarker for identification of melanoma tumor cells | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| MX2019008005A (es) | Metodos y composiciones para diagnosticar preeclampsia. | |
| MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| MX2021009528A (es) | Prueba de diagnostico basada en fragmento de rgma. | |
| PH12014501445B1 (en) | Detection of human umbilical cord tissue-derived cells | |
| WO2013077814A3 (en) | Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy | |
| IN2014DN08312A (es) | ||
| WO2014182972A3 (en) | Diagnostic and monitoring system for huntington's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |